Technical Presentations
All Technical Resources
Filter by our most popular collections of technical resources, or browse the full resource list below.
VeriKine-HS Human IFN-Beta ELISA Product Flyer
Allows accurate Human IFN-β measurement to as low as 1.2 pg/ml in human serum, plasma, autoimmune disease sera or cell culture media
Serum soluble IFNAR2 levels in autoimmune diseases suggest that chronic IFN signaling leads to elevated levels of sIFNAR2
Data from Healthy donors, Systemic Lupus patients, Rheumatoid Arthritis patients, Sjogren's patients, and Scleroderma patients were analyzed
IFN-Beta Therapy increases concentratoin of sIFNAR in MS patient Serum
Results expand upon previous literature which suggests that the mRNA encoding a soluble form of the IFN receptor is increased by long term IFN-beta therapy.
Antiviral Activity of IFN-Alpha Subtypes on Different Cell Lines
The antiviral effect of multiple human and mouse IFN-Alpha subtypes in cell lines derrived from hansters, rats, rhesus, and cynomolgus monkeys were examined
Biological Activities and Detection of Cynomolgus IFN-Alpha Subtypes
Twelve unique Cynomolgus IFN-Alpha proteins were identified, sequenced, cloned and expressed. An ELISA has been developed for the detection of Cynomolgus IFN-Alpha 2 protein.
Binding and Neutralization of Monoclonal Antibodies to Human IFN-Alpha Subtypes
Binding to the IFN-Alpha subtypes was determined by Direct ELISA, IFNAR2 binding, and Sandwich ELISA. Neutralization was determined by ISG-15 based reporter gene assay and CPE in the A549/EMCV system.
Antiviral Activity of Cytokines
This study demonstrates that cytokines which lead to protection from viral challengein A549 cells work primarily through priming the cells to produce IFN-beta upon viral challenge